T 0499/12 (HCV NS3-NS4A protease inhibitors/VERTEX) of 04.04.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T049912.20140404
- Date of decision
- 4 April 2014
- Case number
- T 0499/12
- Online on
- 9 April 2014
- Petition for review of
- -
- Application number
- 04784319.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE
- Applicant name
- Vertex Pharmaceuticals Inc.
- Opponent name
- -
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Amended claims at appeal, specific compounds: novelty, inventive step (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to grant a patent in the following version:
- Description pages 1 to 5, 50 to 55, 64 to 71, 75, and 77 to 102 attached to communication dated 11 February 2014
- Description pages 6 and 76 filed with letter dated 12 February 2014, received on 13 February 2014
- Claims 1 to 7 filed with letter dated 19 March 2014